Clinical Trial Update: Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for Endocrine Against Locoregional Therapy in postmenopausal women with operable breast cancer; trial status terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Operable Breast Neoplasms

Snippet

Sponsor: Danish Breast Cancer Cooperative Group | Conditions: Operable Breast Neoplasms | Phase 3 | Status: TERMINATED